These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35301939)

  • 1. Bone mass density in lean and overweight women with polycystic ovary syndrome.
    Mørch NF; Aziz M; Svendsen PF
    Scand J Clin Lab Invest; 2022 May; 82(3):210-217. PubMed ID: 35301939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of low bone mineral density in premenopausal polycystic ovary syndrome patients.
    Karadağ C; Yoldemir T; Gogas Yavuz D
    Gynecol Endocrinol; 2017 Mar; 33(3):234-237. PubMed ID: 27908213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of bone mineral density with insulin resistance in patients with polycystic ovary syndrome.
    Noyan V; Yucel A; Sagsoz N
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):200-5. PubMed ID: 15262356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome.
    Kirchengast S; Huber J
    Hum Reprod; 2001 Jun; 16(6):1255-60. PubMed ID: 11387301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between bone mineral density and insulin resistance in polycystic ovary syndrome.
    Yüksel O; Dökmetaş HS; Topcu S; Erselcan T; Sencan M
    J Bone Miner Metab; 2001; 19(4):257-62. PubMed ID: 11448019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density in women with polycystic ovary syndrome.
    Katulski K; Slawek S; Czyzyk A; Podfigurna-Stopa A; Paczkowska K; Ignaszak N; Podkowa N; Meczekalski B
    J Endocrinol Invest; 2014 Dec; 37(12):1219-24. PubMed ID: 25245338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance.
    Mario FM; do Amarante F; Toscani MK; Spritzer PM
    Exp Clin Endocrinol Diabetes; 2012 Oct; 120(9):511-6. PubMed ID: 22576259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of Bone Mineral Density in Iranian Women with Polycystic Ovary Syndrome.
    Karimi F; Mardani P
    Int J Endocrinol Metab; 2023 Oct; 21(4):e137594. PubMed ID: 38666045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
    Ságodi L; Lombay B; Vámosi I; Barkai L
    Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome.
    Ganie MA; Chakraborty S; Sehgal A; Sreejith M; Kandasamy D; Jana M; Rashid A
    Horm Metab Res; 2018 Oct; 50(10):754-760. PubMed ID: 30312986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of increased lean muscle mass in women with polycystic ovary syndrome.
    Carmina E; Guastella E; Longo RA; Rini GB; Lobo RA
    Eur J Endocrinol; 2009 Oct; 161(4):583-9. PubMed ID: 19605540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial.
    Glintborg D; Andersen M; Hagen C; Heickendorff L; Hermann AP
    J Clin Endocrinol Metab; 2008 May; 93(5):1696-701. PubMed ID: 18285411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome.
    Yucel A; Noyan V; Sagsoz N
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):81-6. PubMed ID: 16337726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density and body composition in lean women with polycystic ovary syndrome.
    Good C; Tulchinsky M; Mauger D; Demers LM; Legro RS
    Fertil Steril; 1999 Jul; 72(1):21-5. PubMed ID: 10428143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of abdominal obesity in patients with polycystic ovary syndrome on metabolic parameters.
    Franik G; Bizoń A; Włoch S; Pluta D; Blukacz Ł; Milnerowicz H; Madej P
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4755-4761. PubMed ID: 29164590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women With Polycystic Ovary Syndrome Have Comparable Hip Bone Geometry to Age-Matched Control Women.
    McBreairty LE; Zello GA; Gordon JJ; Serrao SB; Pierson RA; Chizen DR; Chilibeck PD
    J Clin Densitom; 2018; 21(1):54-60. PubMed ID: 28034591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of androgens to muscle size and bone mineral density in women with polycystic ovary syndrome.
    Douchi T; Oki T; Yamasaki H; Kuwahata R; Nakae M; Nagata Y
    Obstet Gynecol; 2001 Sep; 98(3):445-9. PubMed ID: 11530127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.